TLIS

Talis Biomedical Corporation

7.28 USD

Last updated Nov 28, 18:57 UTC

Yesterday HIGH

$7.49

Yesterday LOW

$7.16

52w HIGH

$9.75

52w LOW

$4.35

EPS

-8.62

PE

-0.84

Next Earnings

Mar 20, 2024

Overview News Government Trades

Talis Biomedical Corporation stock is up 55.22% since 30 days ago. The next earnings date is Mar 20, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 November’s closed higher than October.

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis 1 COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVI-19.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Measuring And Control Equipment

Headquarters

-

Website

talisbio.com

mahesh@benzinga.com

Thu May 11, 2023

Talis Biomedical Q1 EPS $(0.66) Beats $(0.73) Estimate, Sales $1.22M Beat $250.00K Estimate

Talis Biomedical (NASDAQ:TLIS) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.73) by 9.59 percent. This is a 47.2 percent increase over losses of $(1.25) per share from
Benzinga Insights

Thu May 11, 2023

Earnings Scheduled For May 11, 2023

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its first quarter.
Michael Horton

Tue Apr 11, 2023

Talis Biomedical Says On Apr. 7, Roger Moody Jr. Notified Co. That He Will Step Down As Co.'s CFO, Effective Apr. 21, 2023, Says Appointed Rebecca Markovich To Serve As Interim CFO; Says Intends To Conduct Executive Search For Permanent CFO

-SEC Filing
Benzinga Insights

Thu Mar 23, 2023

Talis Biomedical's Return On Capital Employed Overview
Michael Horton

Wed Mar 22, 2023

Talis Q4 Sales $257K
Lisa Levin

Mon Dec 5, 2022

Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session

Gainers Winc, Inc. (NYSE: WBEV) rose 88.5% to $0.3901 after dropping over 23% on Friday. Winc, last month, posted a Q3 loss of $0.33 per share.
Benzinga Insights

Tue Nov 8, 2022

Stocks That Hit 52-Week Lows On Tuesday

Tuesday's session saw 184 companies set new 52-week lows.
Benzinga Newsdesk

Thu Nov 3, 2022

Talis Biomedical Q3 Sales $800.00K Up From $218.00K YoY

Talis Biomedical (NASDAQ:TLIS) reported $800.00 thousand in sales this quarter. This is a 266.97 percent increase over sales of $218.00 thousand the same period last year.
Benzinga Insights

Tue Oct 25, 2022

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 120 companies set new 52-week lows.
Benzinga Insights

Wed Oct 19, 2022

Stocks That Hit 52-Week Lows On Wednesday

On Wednesday, 200 companies hit new 52-week lows.